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Background and aims: Despite increases in female gambling, little research investigates female-speciﬁc factors
affecting gambling behavior (GB). Although research suggests that some addictive behaviors may ﬂuctuate across
menstrual cycle phase (MCP), gambling requires further investigation. In two studies, we examined associations
between MCP and three risky GBs: time spent gambling, money spent gambling, and the probability of consuming
alcohol while gambling. Associations between MCP and negative affect were also examined in Study 2. We predicted
that, consistent with self-medication theory, increases in negative affect (Study 2) and risky GBs (Studies 1 and 2)
would occur premenstrually/menstrually relative to other phases. Methods: Data were obtained from 33 female
gamblers using a retrospective timeline followback procedure (Study 1) and from 20 female gamblers using a
prospective 32-day, daily diary method (Study 2). In Study 2, salivary progesterone levels veriﬁed self-reported MCP
validity. Results: Findings revealed signiﬁcant, but somewhat inconsistent, MCP effects on GBs across studies. The
self-medication hypothesis was partially supported. Increases relative to another MCP(s) were found for alcohol
consumption while gambling premenstrually, time spent gambling menstrually/premenstrually, money spent
gambling menstrually, and negative affect premenstrually. Unexpectedly, ﬁndings more consistently indicated that
GBs increased during ovulation, suggestive of enhanced reward sensitivity. Progesterone assays validated self-
reported MCP (Study 2). Discussion and conclusions: The results suggest a role of ovarian hormones on negative
affect and GBs in females. This research could lead to the identiﬁcation of female-speciﬁc factors affecting gambling
and the development of more effective interventions for females with, or at risk for, problematic gambling.
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INTRODUCTION
Epidemiological studies suggest 65%–82% of the popula-
tion has gambled on one or more occasion(s) in the past
12 months (Sproston, Hing, & Palankay, 2012; Welte,
Barnes, Wieczorek, Tidwell, & Parker, 2002). Since gam-
bling behavior (GB) is associated with social, psychologi-
cal, and ﬁnancial harms, it is important to identify factors
contributing to increased GB.
Sex differences exist in GB. While males gamble at
higher rates than females (Welte, Barnes, Tidwell, Hoffman,
& Wieczorek, 2015), females begin gambling later (34.2 vs.
20.4 years old, respectively; Tavares, Zilberman, Beites, &
Gentil, 2001), prefer different types of gambling (Hraba &
Lee, 1996), have higher rates of comorbid mood/anxiety
disorders (Ibán˜ez, Blanco, Moreryra, & Saiz-Ruiz, 2003;
Potenza et al., 2001), and are more likely to gamble to
escape/relieve negative mood (Stewart & Zack, 2008).
Extant gambling research has focused on males. This sex
insensitivity is problematic for at least two reasons. First,
recent reports indicate an increased prevalence of GBs in
females, with rates approaching those of males (Richmond-
Rakerd, Slutske, & Piasecki, 2013). Second, interventions
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targeting excessive gambling, stemming from this previous
work, may not generalize to females.
One factor potentially inﬂuencing females’ addictive
behaviors is ovarian hormone ﬂuctuations across the men-
strual cycle (MC; Moran-Santa Maria, Flanagan, & Brady,
2014; Terner & de Wit, 2006). The average MC lasts 23–35
days (Münster, Schmidt, & Helm, 1992), and is subdivided
into the: menstrual (days 1–5), follicular (days 6–12), ovula-
tory (days 13–16), luteal (days 17 to premenstrual phase), and
premenstrual phases (5 days prior to menstruation; Evans,
Haney, Levin, Foltin, & Fischman, 1998; Johannes et al.,
1995; Pastor & Evans, 2003). Mood ﬂuctuations across MC
phase (MCP) are believed to relate to variations in proges-
terone and estrogen concentrations, although no single un-
derlying mechanism has been identiﬁed. Elevated negative
affect is reported premenstrually/menstrually (Richards,
Rubinow, Daly, & Schmidt, 2006) – MCPs characterized
by low estrogen and precipitously decreasing progesterone
levels, respectively (Grifﬁn & Ojeda, 2004).
Addictive behavior motivations are increasingly being
viewed as having state-like features. Situational factors, like
mood, predict addictive behavior motivations (Arbeau,
Kuiken, & Wild, 2011). Self-medication theory (SMT;
Khantzian, 1997) posits that addictive behaviors serve to
reduce/eliminate elevated negative affect. Consistent with
SMT predictions, increased alcohol consumption menstru-
ally was explained by elevated coping motives (Joyce,
Hudson, et al., 2018). Since female gamblers gamble to
cope more frequently than males (Stewart & Zack, 2008),
and if gambling motivation similarly has state-like proper-
ties, females may increase risky GBs premenstrually/
menstrually (vs. other MCPs) to self-medicate elevated
negative affect (Richards et al., 2006). Increased risky GBs
premenstrually/menstrually might include the use of alcohol
while gambling, since problem gamblers have an increased
risk for problematic drinking (Zimmerman, Chelminski, &
Young, 2006). Further examining negative affect and GB
across MCP appears to be a critical step toward identifying
female-speciﬁc gambling factors.
Although ﬁndings vary across studies and the addictive
behavior examined, evidence suggests MCP inﬂuences
substance use/other addictive behaviors. Across substance
use behaviors, results have been inconsistent; however, for
alcohol, cigarettes, and cannabis, the slight majority of
ﬁndings support increased substance use premenstrually
and/or menstrually relative to other MCP, consistent with
SMT predictions (Carroll, Lustyk, & Larimer, 2015; Joyce,
Good, Tibbo, Brown, & Stewart, 2018).
Two studies have examined GBs across MCP in female
auction bidders (Chen, Katuščák, & Ozdenoren, 2013;
Pearson & Schipper, 2013). These studies were longitudinal,
in-laboratory studies assessing the amount of money spent
bidding, and bidding proﬁts obtained, across MCP.
Normally cycling females bid higher and earned lower
proﬁts than the average male during all MCPs except during
the follicular phase (Pearson & Schipper, 2013), suggesting
females engage in less risky GB during the follicular phase.
The results provided partial support for SMT predictions
(i.e., riskier GB premenstrually/menstrually than during the
follicular phase). However, another study suggested that
females bid more during the follicular phase compared to
the male average and female cycle average (Chen et al.,
2013), providing no support for SMT predictions. However,
this study was conducted on females taking hormonal
contraceptives, introducing interpretive problems since
ovarian hormones would not vary naturally across MCP.
Overall, MCP effects on GB are limited to two studies
employing a single index of laboratory-based bidding,
raising issues of generalizability to other forms of gambling
and external validity outside of the laboratory. In addition,
the active form of gambling examined (i.e., auction bidding)
lacks ecological validity as females more commonly gravi-
tate toward passive types of gambling, such as bingo and
slot machines (Hraba & Lee, 1996).
The current studies address the literature gap on whether
GBs vary across females’ MCP through the implementation
of retrospective (Study 1) and prospective (Study 2) re-
search designs examining three indices of risky GB. The
retrospective design allowed for the inclusion of a larger
sample size, reducing error variance, and increasing gener-
alizability. The prospective design reduced memory biases
(Goldstein et al., 2017) and allowed for the collection
of negative affect data, and the biological conﬁrmation of
MCP (e.g., Joyce, Hudson, et al., 2018). However, because
prospective daily diary methods are more demanding versus
other methods, it can be more difﬁcult to ﬁnd participants
willing to provide daily assessments, and data may suffer
due to participant non-compliance. As a result, retrospective
and prospective designs were employed to enhance rigor
and generalizability.
Based on SMT predictions (Khantzian, 1997), and
established increases in negative affect premenstrually/
menstrually (Richards et al., 2006), we predicted that female
gamblers would spend more time and money gambling, and
would display a higher probability of consuming alcohol
while gambling, premenstrually/menstrually versus other
MCPs (Studies 1 and 2). Moreover, based on prior research
(e.g., Richards et al., 2006), we hypothesized females would
report elevated negative affect premenstrually/menstrually
versus other MCPs (Study 2). Finally, we predicted salivary
progesterone levels would be higher during self-reported
MC days 1–7 than self-reported MC days 18–24, thus
validating self-reported MCP (Study 2).
METHODS: STUDY 1
Participants
Thirty-three normally cycling female gamblers (Mage= 29.9
years, SD= 10.1) were recruited through advertisements
(community, campus, and social media). On average, parti-
cipants gambled 5.12 days (SD= 3.66) during the prior
30 days and reported moderate levels of gambling conse-
quences on the Problem Gambling Severity Index (PGSI;
Ferris & Wynne, 2001; M= 5.91, SD= 5.25; scores ranged
from 1 to 25). The majority of participants were low risk
(n= 17), followed by moderate risk (n= 8) and problem
gamblers (n= 8). Females were excluded if they gambled
less than twice in the past month, were not between 19 and
45 years old, were abstaining/trying to abstain from gam-
bling, self-reported a severe mood or psychiatric disorder
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diagnosis (aside from premenstrual dysphoric disorder;
PMDD), experienced interference with their MC [hormonal
contraceptive use, recent/current pregnancy, plans of con-
ceiving, or (post)menopausal], were not normally cycling,
or had a MC length outside of the average 25–32 days.
Measures
Problem Gambling Severity Index (PGSI). The PGSI
(Ferris & Wynne, 2001) is a nine-item questionnaire de-
scribing participants’ gambling severity. An example ques-
tion includes “Have you bet more than you could really
afford to lose?” rated on a 4-point scale from “never” (0) to
“almost always” (3). Responses were summed. Total scores
were interpreted using established cut-offs: 0= non-
problem, 1–4= low risk, 5–7=moderate risk, and
8+= problem gamblers. The PGSI has good internal consis-
tency (α= .84), test–retest reliability over 3–4 weeks (r= .78),
and convergent validity with Lesieur and Blume’s (1987)
South Oaks Gambling Screen (Ferris & Wynne, 2001).
MC Questionnaire (MCQ). The MCQ is an eight-item,
author-compiled questionnaire assessing pregnancy, con-
traceptive use, and MC regularity (e.g., “Are you currently
trying to conceive?”) to conﬁrm participant eligibility. The
most recent ﬁrst day of menstruation was also reported via
the item “Thinking back to your last menstrual period, on
what date did your period begin? (Count the ﬁrst day of
blood ﬂow as day one, not spotting).” A count forward–
backward method, based on an average 28-day cycle,
identiﬁed the participant’s MC day on the Gambling Time-
line Followback (GTLFB). Retrospective recall of the ﬁrst
day of menstruation is an accurate indicator of MC day with
81% of females accurately recalling menstruation within
2 days (Wegienka & Baird, 2005).
Gambling timeline followback (GTLFB). The GTLFB
(Weinstock, Whalen, & Meyers, 2004) is a retrospective
tool assessing participants’ GB 30 days prior. A calendar
was labeled with signiﬁcant occasions during the past
30 days, to act as memory anchors. For each gambling
occasion during the prior 30 days, participants reported the
amount of time [“How much time did you spend gambling
(in minutes)?”] and money spent gambling [“How much
money did you spend gambling (in Canadian dollars)?”], and
whether alcoholic beverages were consumed while gambling
[“How many drinks did you consume while gambling
(number of standard drinks)?;” coded as yes/no for analysis
purposes]. A standard drink was speciﬁed as: one beer; one
cooler; one 4-oz. glass of wine; or one shot/mixed drink
containing 1-oz. of hard liquor. The three questions asked
have acceptable to excellent test–retest reliability across a
6-month period [i.e., time spent (r= .79), money spent
(r= .96), and drinks consumed (r=. 94)] and good concur-
rent and discriminant validity (Weinstock et al., 2004).
Procedure
Study 1 data were obtained between October 2013 and May
2015. A telephone screening determined eligibility. Those
eligible females were invited to an in-laboratory session
where they completed the PGSI, MCQ, and GTLFB. Parti-
cipants were compensated $40/CDN.
Statistical analysis
Data were standardized to an average 28-day cycle using a
phasic standardization procedure developed by Joyce and
Stewart (in press). Gambling variables were then calculated
as rates per phase to account for variations in MCP length
[Variability in total MC length could not be accounted for in
Study 1; this was a limitation of the retrospective design used.
To account for this limitation in Study 2, MC length vari-
ability was accounted for by including a variable number of
days in the luteal phase for females with cycles greater than
28 days (see Joyce & Stewart, in press). For females with
cycles less than 32 days, only days within a full MC were
used (and the rest were excluded)]. Time and money spent
gambling were calculated as totals per phase and divided by
the number of days gambled during each phase. The number
of days where alcohol was consumed while gambling per
phase was divided by the number of days gambled per phase.
Missing data was then imputed using multiple imputations
and data analyses were conducted using SPSS (IBM Corp.
Released 2015, IBM SPSS Statistics for Windows, version
23.0. Armonk, NY, USA). Composite variables were devel-
oped for each GB by collapsing participant data across MCP,
providing a variable for the average time and money spent
gambling, and the proportion of gambling occasions where
alcohol was consumed, over the prior 30 days. Bivariate
correlations were conducted to examine overlap between
these three GBs, irrespective of MCP. For hypothesis tests
involving all three risky GBs, sets of non-parametric Wil-
coxon rank tests compared each GB across MCP. Parametric
tests rely on large sample sizes, normal distributions, and are
inﬂuenced by outliers; thus, non-parametric analyses were
employed due to the study’s small sample size.
Ethics
The procedures of Studies 1 and 2 abided by the Declaration
of Helsinki. Studies 1 and 2 were approved by research
ethics boards at Dalhousie University (Studies 1 and 2), the
University of Toronto (Studies 1 and 2), Concordia Univer-
sity (Study 2), and the University of Manitoba (Study 1).
All participants provided informed consent prior to
participation.
RESULTS
Bivariate correlations, collapsed across MCP, indicated that
the amount of time and money spent gambling were signiﬁ-
cantly intercorrelated. None of the remaining correlations
were signiﬁcant (Table 1). The general independence of the
three dependent variables justiﬁed their examination as
independent outcomes.
The total amount of time spent gambling per gambling
occasion differed by MCP. Inconsistent with SMT predic-
tions, females spent less time gambling per gambling occa-
sion menstrually (Mdn= 45.00; range= 240.00) than during
the follicular (Mdn= 70.34; range= 235.00), ovulatory
(Mdn= 104.58; range= 300.00), and luteal (Mdn= 81.69;
range= 300.00) phases, and more time gambling per
gambling occasion during ovulation than premenstrually
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(Mdn= 47.16; range= 299.00; Figure 1a; Table 2). The
amount of money spent per gambling occasion did not
differ based on MCP (Figure 1b; Table 2).
The probability of drinking alcohol while gambling
differed by MCP. Partially consistent with SMT predictions,
the probability of drinking alcohol while gambling
was greater premenstrually (Mdn= 0.33; range= 1) than
during the follicular (Mdn= 0.00; range= 1; marginally
signiﬁcant) and luteal phases (Mdn= 0.00; range= 1;
Figure 1c). The probability of consuming alcohol while
gambling was also greater during ovulation (Mdn= 0.39;
range= 1) than all other MCPs (Figure 1c; Table 2).
Table 1. Summary of means, standard deviations, and intercorrelations for money and time spent gambling, the probability of consuming
alcohol while gambling, and negative affect
Measures 1 2 3 4 M Mdn SD
1. Money spent gambling (dollars) – .375* −.105 84.64 35.92 99.00
2. Time spent gambling (minutes) .223 – .077 85.02 84.22 55.08
3. Alcohol consumption while gambling .081 .184 – .30 .20 .29
4. Negative affect −.210 .032 .071 –
M 25.69 95.86 .38 15.60
Mdn 24.55 74.14 .41 10.76
SD 12.13 103.91 .18 14.10
Note. Intercorrelations for Study 1 (n= 33) are presented above the diagonal, and intercorrelations for Study 2 (n= 20) are presented below
the diagonal. Means and standard deviations (SDs) for Study 1 are presented in the vertical columns, whereas the means and SDs for Study 2
are presented in the horizontal columns. Negative affect was not measured in Study 1; thus, correlations, mean, median, and standard
deviations are not included. All tests were two-tailed.
*Signiﬁcance at the p< .05 level.
(a) (b)
(c)
Figure 1. Average time (minutes) spent gambling per gambling occasion (a), money (Canadian dollars) spent gambling per gambling occasion
(b), and probability of drinking while gambling (c) across menstrual cycle phase in retrospective Study 1. Error bars represent standard errors.
Note. Asterisk (*) indicates signiﬁcantly higher levels of gambling behavior when compared to at least one other menstrual cycle phase
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METHODS: STUDY 2
Participants
Twenty normally cycling female gamblers (Mage= 30.7
years, SD= 9.48) were recruited via the methods used in
Study 1. On average, participants gambled 5.25 times
(SD= 3.78) during their 32 days of study participation.
Participants reported average MC lengths (M= 29.1 days,
SD= 3.74) and similar average PGSI scores (M = 4.60,
SD= 4.81; scores ranged from 0 to 21) to Study 1 partici-
pants. The majority of participants were low risk (n= 12),
followed by problem (n= 4), moderate risk (n= 3), and
non-problem (n= 1) gamblers. Inclusion/exclusion criteria
were identical to those in Study 1.
Daily diary measures
MC day. Participants identiﬁed their MC day daily, with day
one being the ﬁrst day of menstruation (i.e., “Please indicate
your MC day, if known, with Day 1 being the ﬁrst day of
menstruation”). If MC day was unknown, participants
indicated “unknown” until menstruation began. Reporting
MC day [vs. menstruation is occurring (yes/no)] is superior
for determining MCP, as variable MC lengths are captured
and errors determining the ﬁrst day of menstruation are
reduced (e.g., if a survey is missed; Joyce, Hudson, et al.,
2018).
Gambling assessment. GB was measured prospectively,
using questions identical to those on the retrospective
GTLFB (Weinstock et al., 2004; Since GBs were reported
for the previous day, a lag procedure was used for data
scoring, where GBs were shifted back one day to align with
the day during which the GBs occurred).
Negative affect assessment. State negative affect items
were drawn from prior research (Grant, Stewart, & Birch,
2007). Participants were presented with six negative affect
adjectives (i.e., “sad,” “depressed,” “blue,” “nervous,”
“anxious,” and “tense”). The participant rated the extent to
which she currently experienced each adjective using a
Visual Analog Scale, with the scale ranging from “not at
all” to “very.” For scoring purposes, “not at all” was coded
as zero; whereas “very” was coded as 100, with possible
scores ranging anywhere between these two values. Nega-
tive affect adjective scores were ﬁrst averaged per day,
producing an overall negative affect score per participant,
Table 2. Summary of Study 1 Wilcoxon rank tests of money spent gambling, time spent gambling, and alcohol consumed, while gambling
across menstrual cycle phase pairs
Variable MCP pair Z p r
Dollars spent Menstrual–follicular 0.745 .456 .130
Menstrual–ovulatory 0.831 .406 .145
Menstrual–luteal 0.168 .866 .029
Menstrual–premenstrual 0.333 .736 .058
Follicular–ovulatory 1.260 .208 .219
Follicular–luteal 0.049 .961 .009
Follicular–premenstrual 0.157 .875 .027
Ovulatory–luteal 0.785 .432 .137
Ovulatory–premenstrual 1.162 .245 .202
Luteal–premenstrual 0.524 .601 .091
Alcohol consumed Menstrual–follicular 0.871 .384 .151
Menstrual–luteal 1.856 .063 .323
Menstrual–premenstrual 0.532 .595 .092
Follicular–luteal 0.734 .463 .128
Ovulatory–menstrual 2.158 .031* .376
Ovulatory–follicular 2.653 .008* .462
Ovulatory–luteal 3.752 <.001* .653
Ovulatory–premenstrual 2.173 .030* .378
Premenstrual–follicular 1.960 .050** .341
Premenstrual–luteal 2.596 .009* .452
Time spent Menstrual–luteal 2.515 .012* .438
Menstrual–premenstrual 0.720 .472 .125
Follicular–menstrual 2.440 .015* .425
Follicular–ovulatory 0.898 .369 .156
Follicular–luteal 0.206 .837 .036
Follicular–premenstrual 1.460 .144 .254
Ovulatory–menstrual 2.811 .005* .489
Ovulatory–luteal 0.972 .331 .169
Ovulatory–premenstrual 2.478 .013* .431
Luteal–premenstrual 1.284 .199 .224
Note. All signiﬁcant and marginally signiﬁcant results are represented in bold. Directionality of each effect is shown in the “MC phase pair”
column, with the highest value presented ﬁrst. The column “r” refers to the effect size of each phase comparison conducted (small effect
size= 0.1; medium effect size= 0.3; large effect size= 0.5). MCP: menstrual cycle phase.
*Signiﬁcant differences at the p< .05 level. **Marginal signiﬁcance at the p< .06 level.
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per MC day. Phasic negative affect scores were calculated as
totals per phase divided by the number of days within that
MCP.
Procedure
Study 2 data were obtained between September 2016 and
April 2017. Study 2 consisted of four phases: telephone
screening, initial in-person assessment, 32 days of daily
diary surveys and saliva collection in vivo, and an in-person
debrieﬁng session. The telephone screening determined
eligibility. If eligible, the participant was invited to attend
an initial assessment where she was instructed on how to
complete daily diary surveys and collect saliva samples.
Everyday for 32 days following the initial assessment,
participants collected daily saliva samples and received
daily diary text messages (at 10:30 a.m.), which provided
links to a survey on the Internet. Due to variability in MC
length, participants were monitored for 32 days, maximizing
the likelihood of obtaining data across an entire MC
(accommodating longer MC lengths). Participants were
instructed to provide saliva samples simultaneously daily
and to store samples in a freezer until returned. Once the
daily surveys and saliva collection were completed, saliva
samples were returned via a provided cooler. Proper storage
was veriﬁed with participants. During debrieﬁng, full infor-
mation on the study’s purpose was available and participants
could ask questions. Participants were compensated up to
$130/CDN. Compensation depended on how many daily
surveys and saliva samples were provided to encourage
compliance.
In the laboratory, saliva samples were stored in a
research-grade freezer (−30 °C) until progesterone assays
were performed. The maximum period of storage was
8 months, as hormone concentrations remain stable without
signiﬁcant degradation during this period (Latendresse &
Ruiz, 2009). Salivary progesterone concentrations are
non-invasive, reliable indicators of MCP designation
(Andreano & Cahill, 2010; Tallon et al., 1984). Salivary
progesterone concentrations were assessed using two sam-
ples during MCPs of theoretical low (days 1–7) and high
(days 18–24) progesterone concentrations (Andreano &
Cahill, 2010) using Salimetrics (State College, PA)
ELISA kits.
Statistical analysis
The analytic strategy of Study 2 GBs was identical to that in
Study 1. In addition, internal consistency was calculated for
the negative affect scores [Internal consistency between the
six negative affect items were calculated at ﬁve time points
across the MC. Self-reported negative affect item data was
analyzed during the middle day of each MCP. In the case
that the number of days within a given MCP were even
(i.e., there was not a single middle MC day), scores for each
negative affect item were consistently taken from the later of
the two middle MC days. That is, during the ovulatory phase
(consisting of MC days 13–16), negative affect item scores
were analyzed for MC day 15] andWilcoxon rank tests were
used to compare negative affect across MCP. Negative
affect and GB data were further collapsed across MCP,
providing average self-reported negative mood and average
GBs across the entire MC. Bivariate correlations were then
calculated for all negative affect and risky GB variables to
examine their overlap irrespective of MCP. Finally, a
dependent sample t-test examined progesterone concentra-
tions at two predetermined MCPs to validate self-reported
MCP.
RESULTS
None of the correlations between the four dependent vari-
ables were signiﬁcant when collapsed across MCP (Table 1).
This independence of the dependent variables justiﬁed their
examination as independent outcomes.
The amount of time spent gambling per gambling occa-
sion differed by MCP. Partially consistent with SMT pre-
dictions, females spent more time gambling per gambling
occasion menstrually (Mdn= 60; range= 220.00) than dur-
ing the follicular phase (Mdn= 42.54; range= 87.50) and
more time gambling per gambling occasion premenstrually
(Mdn= 103.08; range= 925.00) than during the follicular,
ovulatory (Mdn= 69.46; range= 137.50), and luteal phases
(Mdn= 68.36; range= 160.00). Unexpectedly, females
spent more time gambling per gambling occasion during
ovulation than the follicular phase (Figure 2a; Table 3).
The amount of money spent gambling per gambling
occasion differed by MCP. Partially consistent with SMT
predictions, females spent more money per gambling occa-
sion menstrually (Mdn= 33.92; range= 97.00) than during
the follicular (Mdn= 12.53; range= 26.00), luteal (Mdn=
20.49; range= 72.00), and premenstrual phases (Mdn=
6.83; range= 73.00). However, in direct contrast to SMT
predictions, less money was spent per gambling occasion
premenstrually versus all other MCPs. Females also
spent more money per gambling occasion during ovulation
(Mdn= 39.03; range= 196.00) than the follicular, luteal,
and premenstrual phases (Figure 2b; Table 3).
The probability of drinking alcohol while gambling
differed based on MCP. In contrast to SMT predictions,
the probability of drinking alcohol while gambling was
greater during ovulation (Mdn= 0.615; range= 1) than the
menstrual (Mdn= 0.302; range= 1), follicular (Mdn=
0.205; range= 1), and premenstrual phases (Mdn= 0.325;
range= 1; Figure 2c; Table 3).
Internal consistency for the six negative affect items
ranged from acceptable (α= .774) to excellent (α= .938).
Negative affect differed based on MCP. Consistent with
SMT predictions, negative affect was greater premenstrually
(Mdn= 14.28; range= 57.23) than during the luteal phase
(Mdn= 7.55; range= 41.33) and marginally greater men-
strually (Mdn= 10.67; range= 59.28) than during ovulation
(Mdn= 6.05; range= 49.00; Figure 2d; Table 3).
Progesterone assays
For Study 2, progesterone assays were conducted using two
samples per MCP of interest per participant. The ﬁrst sample
assayed was where, according to self-reported MC day,
progesterone concentrations should have been highest (days
18–24) or lowest (days 1–7; Andreano & Cahill, 2010).
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The second sample was from 1 day before the ﬁrst sample
(n= 10), or in the case of unavailable/contaminated sam-
ples, the closest sample to the ﬁrst sample (n= 4; all within
2 days of the empty/spoiled sample) [Progesterone concen-
tration assays were completed for 70% of participants
(14 out of 20) as four participants (20%) did not return
their saliva samples following study completion, and pro-
gesterone concentrations were outside of the detectable
range for two participants (10%) likely due to improper
storage]. Within both phases, the two samples were highly
correlated [r’s= .88 (days 1–7), and .83 (days 18–24)], so
they were averaged within phase. Averaged values showed a
MCP effect [t(13) = 2.82, p= .014] with progesterone
concentrations signiﬁcantly higher, on average, during days
18–24 than days 1–7 [M’s (SE’s)= 135.13(38.38) vs. 64.51
(21.06) pg/ml, respectively], as expected, providing valida-
tion for self-reported MCP.
DISCUSSION
The multimethod approach used here provided the ﬁrst
thorough examination of differences in various GBs across
female gamblers’ MCs. Based on SMT (Khantzian, 1997),
we hypothesized female gamblers would engage in riskier
GBs and experience higher levels of negative affect
premenstrually/menstrually versus other MCPs. Findings
provided partial support for SMT predictions. Unexpected-
ly, the results more consistently suggested female gamblers
engage in riskier GBs during ovulation.
Both studies partially supported SMT predictions.
Study 1 found an increased probability of consuming
alcohol while gambling premenstrually [relative to the
luteal and follicular (marginal signiﬁcance) phases].
However, these effects were not replicated in prospective
Study 2. In addition, Study 2 found increases in the amount
of time spent gambling menstrually and premenstrually
(relative to the follicular phase, and to the follicular,
ovulatory, and luteal phases, respectively). However, these
effects were not observed in retrospective Study 1. Study 2
also found increases in the amount of money spent gam-
bling menstrually (relative to the follicular, luteal, and
premenstrual phases), but again this effect was not ob-
served in Study 1. In direct contrast to SMT predictions,
however, Study 1 found that time spent gambling per
gambling occasion was lower menstrually (relative to the
follicular, ovulatory, and luteal phases) and Study 2 found
the amount of money spent gambling was lowest
(a)
(c) (d)
(b)
Figure 2. Average time (minutes) spent gambling per gambling occasion (a), money (Canadian dollars) spent gambling per gambling
occasion (b), the probability of drinking while gambling (c), and negative affect (d) across menstrual cycle phase in the prospective Study 2.
Error bars represent standard errors. Note. Asterisk (*) indicates signiﬁcantly higher levels and a cross symbol (†) indicates marginally
signiﬁcant higher levels of gambling behavior/negative affect relative to at least one other menstrual cycle phase
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premenstrually (relative to all other MCP) and the proba-
bility of consuming alcohol while gambling was lower
menstrually and premenstrually (relative to the ovulatory
phase).
SMT predictions (Khantzian, 1997) were based on
established increases in depressed mood premenstrually/
menstrually (Richards et al., 2006). Consistent with this
prior work, we showed that negative affect increased pre-
menstrually (relative to the luteal phase) and marginally
increased menstrually (relative to the ovulatory phase).
This shows that it was not the absence of expected
negative affect changes across MCP explaining this failure to
consistently obtain expected increases in GB menstrually/
premenstrually. It is plausible that GBs increase premen-
strually/menstrually only for a subset of female gamblers
who experience severely increased dysphoria premenstrually/
menstrually (e.g., those with PMDD; see DSM-5,
American Psychiatric Association, 2013). Unfortunately,
our small sample in Study 2 and lack of negative affect
data in Study 1 precluded an examination of this possibility
in our data. Thus, future research could compare GB ﬁnd-
ings across the MC for females with high versus low levels
of PMDD symptoms to test whether SMT is more relevant
for female gamblers with high PMDD with respect to GB
Table 3. Summary of Study 2 Wilcoxon rank tests of money spent gambling, time spent gambling, alcohol consumed while gambling, and
negative affect across menstrual cycle phase pairs
Variable MCP pair Z p r
Dollars spent Menstrual–follicular 3.340 .001* .747
Menstrual–luteal 2.439 .015* .545
Menstrual–premenstrual 3.136 .002* .701
Follicular–premenstrual 2.052 .040* .459
Ovulatory–menstrual 1.643 .100 .367
Ovulatory–follicular 3.659 <.001* .818
Ovulatory–luteal 3.114 .002* .696
Ovulatory–premenstrual 3.211 .001* .718
Luteal–follicular 1.808 .071 .404
Luteal–premenstrual 2.455 .014* .549
Alcohol consumed Menstrual–follicular 0.966 .334 .216
Ovulatory–menstrual 2.722 .006* .609
Ovulatory–follicular 3.245 .001* .726
Ovulatory–luteal 1.208 .227 .270
Ovulatory–premenstrual 3.527 <.001* .789
Luteal–menstrual 1.294 .196 .289
Luteal–follicular 2.172 .030* .486
Luteal–premenstrual 2.274 .023* .508
Premenstrual–menstrual 1.061 .289 .237
Premenstrual–follicular 0.345 .730 .077
Time spent Menstrual–follicular 2.501 .012* .561
Ovulatory–menstrual 1.415 .157 .316
Ovulatory–follicular 2.613 .009* .584
Ovulatory–luteal 0.762 .446 .170
Luteal–menstrual 1.248 .212 .279
Luteal–follicular 2.367 .018* .529
Premenstrual–menstrual 1.269 .204 .284
Premenstrual–follicular 3.361 .001* .752
Premenstrual–ovulatory 2.314 .021* .517
Premenstrual–luteal 2.173 .030* .486
Negative affect Menstrual–ovulatory 1.941 .052** .434
Menstrual–luteal 1.755 .079 .392
Follicular–menstrual 0.485 .627 .108
Follicular–ovulatory 0.966 .334 .216
Follicular–luteal 1.493 .135 .334
Luteal–ovulatory 0.196 .845 .044
Premenstrual–menstrual 0.597 .940 .133
Premenstrual–follicular 0.635 .526 .142
Premenstrual–ovulatory 1.792 .073 .401
Premenstrual–luteal 1.979 .048* .443
Note. All signiﬁcant and marginally signiﬁcant results are represented in bold. Directionality of each effect is shown in the “MCP pair”
column, with the highest value presented ﬁrst. The column “r” refers to the effect size of each phase comparison conducted (small effect
size= 0.1; medium effect size= 0.3; large effect size= 0.5). MCP: menstrual cycle phase.
*Signiﬁcant differences between menstrual cycle phase at the p< .05 level. **Marginal signiﬁcance at the p< .06 level.
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across MCP. Future research could also investigate whether
SMT predictions are borne out more consistently for female
gamblers with diagnosed mood disorders (e.g., depression
and anxiety). Herein, participants self-reporting a mood or
psychiatric disorder diagnosis were excluded. Incorporating
diagnostic measures, such as the Structured Clinical Inter-
view for DSM-5 Disorders (First, Williams, Karg, &
Spitzer, 2015), to identify females with mood/anxiety dis-
orders to ensure more rigorous assessment of the presence of
these psychopathologies may be beneﬁcial.
Since depressed individuals are more likely to report
wanting to be secluded from others (Larson, Raffaelli,
Richards, Ham, & Jewell, 1990), females with signiﬁcant
PMDD symptomatology may engage in more solitary GB to
self-medicate premenstrually/menstrually relative to female
gamblers without high PMDD symptomatology. Future
research should examine this, as the association between
MCP and social gambling context (solitary vs. social;
Quinlan, Goldstein, & Stewart, 2013) was not explored in
the current studies.
Unexpectedly, ﬁndings more consistently suggested
risky GBs increased during ovulation versus at least one
other MCP. This increase in risky GBs during ovulation
may be attributable to ﬂuctuations in ovarian hormones and/
or variations in positive mood across MCP. The surge in
estrogen occurring during ovulation produces elevated sen-
sitivity to rewards (Dreher et al., 2007; Sakaki & Mather,
2012). Thus, female gamblers may increase their risky GBs
to optimize perceived gambling-related rewards. Females
also report their most positive mood during ovulation
(Collins, Eneroth, & Landgren, 1985); thus, it is possible
that increased positive mood during ovulation prompts
increased enhancement-motivated gambling to maximize
positive mood experiences. Others should examine whether
ﬂuctuations in GB across MCP are mediated by changes in:
gambling motives (state enhancement and/or coping; see
Joyce, Hudson, et al., 2018, for a similar approach used for
alcohol), and/or ovarian hormone concentrations (collected
via daily hormonal assessments). Although these ovulatory
phase-related ﬁndings are informative, they should be inter-
preted with caution as the present studies were not designed
to detect the precise timing of ovulation. Future research
should assess luteinizing hormone concentrations daily
to more accurately pinpoint ovulation (Nardelli-Haeﬂiger
et al., 2003).
Findings could be used as a psychoeducational tool for
female gamblers and to inform interventions for females
experiencing, or at risk for, comorbid gambling and alcohol
use problems. Providing information on the relationship
between MCP and risky GBs could enhance awareness of
MCPs where GBs may increase, allowing for the implemen-
tation of harm-reduction strategies to minimize GBs at riskier
phases. Findings emphasize how using strategies to manage
increases in reward sensitivity during ovulation may be
beneﬁcial upon implementing gambling interventions. If
abstaining from gambling is the goal of treatment, initiating
cessation attempts at lower-risk MCPs may enhance the
likelihood of success; similar recommendations have been
made for tobacco cessation based on MCP variability in
smoking behavior (Mendrek, Dinh-Williams, Bourque, &
Potvin, 2014).
This study provides the ﬁrst multimethod approach
examining various GBs across an entire MC. Support for
SMT was not consistent across retrospective and prospec-
tive methodologies, in which GBs were sometimes, but not
always, found to increase premenstrually/menstrually versus
another MCP(s). Unexpectedly, GBs quite consistently
increased during ovulation. When results conﬂict between
studies, we recommend emphasizing the prospective Study
2 results, given their reduced reliance on retrospective
memory, our simultaneous assessment of negative affect,
and our ability to validate MCP via progesterone assays.
The results bring into question the reliability of employing
retrospective methodologies in this area of research. Find-
ings provide researchers with a more comprehensive under-
standing of how MCP inﬂuences females’ GB and could aid
in the development of more effective female-speciﬁc gam-
bling harm-reduction tools.
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